PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape by Bright Chukwunwike Uzuegbunam, Damiano Librizzi, Behrooz Hooshyar Yousefi

Get full text

Radiotracers for Imaging of Inflammatory Biomarkers TSPO and COX-2 in the Brain and in the Periphery by Bright Chukwunwike Uzuegbunam, Christoph Rummel, Damiano Librizzi, Carsten Culmsee, Behrooz Hooshyar Yousefi

Get full text

Clinical Relevance of [¹⁸F]Florbetaben and [¹⁸F]FDG PET/CT Imaging on the Management of Patients with Dementia by Damiano Librizzi, Nicole Cabanel, Maxim Zavorotnyy, Elisabeth Riehl, Tilo Kircher, Markus Luster, Behrooz Hooshyar Yousefi

Get full text

In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker by Bright C. Uzuegbunam, Junhao Li, Wojciech Paslawski, Wolfgang Weber, Per Svenningsson, Hans Ågren, Behrooz Hooshyar Yousefi

Get full text

Toward Novel [18F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils by Bright C. Uzuegbunam, Junhao Li, Wojciech Paslawski, Wolfgang Weber, Per Svenningsson, Hans Ågren, Behrooz Hooshyar Yousefi

Get full text

Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007 by Stephanie Robu, Alexander Schmidt, Matthias Eiber, Margret Schottelius, Thomas Günther, Behrooz Hooshyar Yousefi, Markus Schwaiger, Hans-Jürgen Wester

Get full text